TARRY(300976)
Search documents
达瑞电子(300976) - 关于完成工商变更登记并换发营业执照的公告
2025-10-28 07:50
证券代码:300976 证券简称:达瑞电子 公告编号:2025-086 东莞市达瑞电子股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或者重大遗漏。 东莞市达瑞电子股份有限公司(以下简称"公司")于 2025 年 4 月 23 日召 开第三届董事会第二十一次会议、于 2025 年 5 月 19 日召开 2024 年年度股东大 会,审议通过了《关于变更注册资本及修订<公司章程>并办理工商变更登记的 议案》,具体内容详见公司于 2025 年 4 月 25 日和 2025 年 5 月 19 日在巨潮资讯 网(www.cninfo.com.cn)披露的《关于变更注册资本及修订<公司章程>并办理 工商变更登记的公告》(公告编号:2025-038)、《2024 年年度股东大会决议公告》 (公告编号:2025-048)等相关公告。公司于 2025 年 6 月 30 日召开第四届董事 会第二次会议、于 2025 年 7 月 17 日召开 2025 年第三次临时股东会,审议通过 了《关于增加经营范围并修订<公司章程>的议案》,具体内容详 ...
达瑞电子(300976) - 关于2022年限制性股票激励计划首次授予第三个归属期及预留授予第二个归属期归属结果暨股份上市的公告
2025-10-27 11:18
证券代码:300976 证券简称:达瑞电子 公告编号:2025-084 东莞市达瑞电子股份有限公司 关于 2022 年限制性股票激励计划首次授予第三个归属期及 预留授予第二个归属期归属结果暨股份上市的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或者重大遗漏。 重要内容提示: 1、本次第二类限制性股票归属股票上市流通安排:本次归属股票的上市流 通日为2025年10月29日; 2、本次第二类限制性股票归属数量98.924万股(首次授予部分92.064万股, 预留授予部分6.86万股),归属人数为103人(首次授予部分100人,预留授予部 分4人,其中1名激励对象同时归属首次及预留部分限制性股票); 3、本次归属股票来源:公司向激励对象定向发行公司A股普通股股票。 东莞市达瑞电子股份有限公司(以下简称"公司")于 2025 年 10 月 16 日召 开第四届董事会第五次会议,审议通过了《关于 2022 年限制性股票激励计划首 次授予第三个归属期归属条件成就的议案》《关于 2022 年限制性股票激励计划预 留授予第二个归属期归属条件成就的议案》。首次授予第二类限制性股票第 ...
达瑞电子:公司入选国家级第七批专精特新“小巨人”企业
Mei Ri Jing Ji Xin Wen· 2025-10-27 11:16
Core Viewpoint - Darui Electronics has been recognized as a national-level "specialized, refined, and innovative" small giant enterprise, which may enhance its market position and growth potential [1] Company Summary - Darui Electronics (SZ 300976) announced its inclusion in the seventh batch of national-level specialized and innovative small giant enterprises as per the announcement from the Guangdong Provincial Department of Industry and Information Technology [1] - As of the announcement date, the public notice period for the selected list has ended [1] - For the year 2024, Darui Electronics' revenue composition is entirely from the manufacturing sector, accounting for 100.0% [1] - The current market capitalization of Darui Electronics is 9.4 billion yuan [1]
达瑞电子(300976) - 关于公司入选国家级专精特新“小巨人”企业的公告
2025-10-27 10:54
东莞市达瑞电子股份有限公司 关于公司入选国家级专精特新"小巨人"企业的公告 证券代码:300976 证券简称:达瑞电子 公告编号:2025-085 一、基本情况 根据广东省工业和信息化厅发布的《关于广东省第七批专精特新"小巨人" 企业和 2025 年专精特新"小巨人"复核通过企业名单的公示》,东莞市达瑞电 子股份有限公司(以下简称"公司")入选国家级第七批专精特新"小巨人"企 业。截至本公告披露日,入选名单的公示期已结束。 二、对公司的影响 专精特新企业是指具备"专业化、精细化、特色化、新颖化"特征的中小企 业。专精特新"小巨人"企业通常位于产业基础核心领域、产业链关键环节,创 新能力突出、掌握核心技术、细分市场占有率高、质量效益优,是优质中小企业 的核心力量。 公司继被认定为 2022 年广东省专精特新中小企业后,入选国家级第七批专 精特新"小巨人"企业,体现了公司在研发创新能力、业务发展前景等方面的综 合实力得到了有关政府部门的充分认可。这有利于提升公司的核心竞争力和行业 影响力,对公司的长远发展具有积极作用。 三、风险提示 公司本次入选国家级第七批专精特新"小巨人"企业,不会对公司当期经营 业绩产生重大 ...
达瑞电子2025前三季营收净利双增 股价6个月涨113%北向资金加仓
Chang Jiang Shang Bao· 2025-10-21 00:04
Core Viewpoint - Darui Electronics (300976.SZ) has achieved significant growth in its performance for the first three quarters of 2025, driven by its dual focus on "consumer electronics" and "new energy" sectors, with a revenue of 2.278 billion yuan and a net profit of 231 million yuan, reflecting year-on-year increases of 28.59% and 26.84% respectively [1][2]. Group 1: Financial Performance - In the first three quarters of 2025, Darui Electronics reported a revenue of 2.278 billion yuan, up 28.59% year-on-year, and a net profit of 231 million yuan, up 26.84% year-on-year [1][2]. - For the third quarter of 2025, the company achieved a revenue of 873 million yuan, representing a year-on-year growth of 29.48%, and a net profit of approximately 98.94 million yuan, which is a 28.92% increase year-on-year [3]. Group 2: Market Position and Strategy - Darui Electronics has established a strong customer base in the consumer electronics sector, including major brands such as Apple, Sony, and Microsoft, and has successfully entered the supply chains of leading companies in the new energy sector like CATL, BYD, and Tesla [1][4]. - The company has strategically positioned itself in the new energy market since 2022, focusing on the development of structural and functional components, which has contributed to its revenue growth [2][4]. Group 3: Growth Drivers - The growth in Darui Electronics' performance is attributed to the recovery in the consumer electronics market driven by advancements in AI models and the increasing demand for power and energy storage batteries in the global new energy vehicle market [2]. - The company’s revenue from the consumer electronics business reached 807 million yuan in the first half of 2025, a year-on-year increase of 5.91%, while the new energy business revenue was 585 million yuan, up 81.32% year-on-year, driven by large orders from key customers and an increase in high-value products [4]. Group 4: Strategic Acquisitions - In 2025, Darui Electronics acquired Vistech to enhance its product offerings, integrating a full system solution for "glass fiber-carbon fiber" and advancing lightweight material research to meet the needs of high-end consumer electronics and AI sectors [5]. - Vistech specializes in carbon fiber products used in various consumer electronics applications, including components for foldable screens, and has established a leading position in product quality metrics [5].
达瑞电子前三季度实现营收22.78亿元,净利润同比增长26.84%
Ju Chao Zi Xun· 2025-10-20 11:02
Core Viewpoint - Darui Electronics (300976) reported strong financial performance for the third quarter of 2025, with significant year-on-year growth in revenue and net profit, indicating a robust operational status and effective business strategies [1][2]. Financial Performance - For the first three quarters, the company achieved total revenue of 2.278 billion yuan, a year-on-year increase of 28.59% [1][2]. - The net profit attributable to shareholders reached 231 million yuan, up 26.84% year-on-year, while the net profit excluding non-recurring gains and losses was 217 million yuan, reflecting a 33.02% increase [1][2]. - In the third quarter alone, revenue was 873 million yuan, representing a 29.48% increase compared to the same period last year, with net profit at approximately 99 million yuan, up 28.92% [1][2]. Asset and Equity Growth - As of the end of the third quarter, total assets amounted to 4.327 billion yuan, marking a 3.7% increase from the end of the previous year [1][2]. - The equity attributable to shareholders was approximately 3.524 billion yuan, reflecting a growth of 3.36% compared to the previous year [2]. Business Expansion - The company completed a controlling acquisition of Weiste New Materials Technology Co., enhancing its market position in carbon fiber composite materials, which will provide optimal solutions for high-end consumer electronics [3]. - Darui Electronics' wholly-owned subsidiary, Shenzhen Ruichuang Future Investment Co., participated in investing in Shenzhen Zhuoyuan Darui Artificial Intelligence Venture Capital Partnership, further aligning with the company's core business in hard technology projects [3].
今日8家公司公布三季报 1家业绩增幅翻倍
Zheng Quan Shi Bao Wang· 2025-10-20 06:13
Core Insights - On October 20, a total of 8 companies released their Q3 2025 financial reports, with 4 companies reporting year-on-year profit growth and 4 reporting declines [1] - Among these companies, 6 reported year-on-year revenue growth, while 2 experienced declines [1] - Companies that saw simultaneous growth in both net profit and revenue include Xingwang Yuda and two others, while Xiangsheng Medical reported declines in both metrics [1] - The company with the highest profit growth rate was Xingwang Yuda, achieving a remarkable increase of 260.00% [1] Company Performance Summary - **Xingwang Yuda (002829)** - Earnings per share: 0.1800 CNY - Net profit: 38.37 million CNY - Net profit year-on-year growth: 260.00% - Revenue: 266.43 million CNY - Revenue year-on-year growth: 14.97% [1] - **Yangjie Technology (300373)** - Earnings per share: 1.8557 CNY - Net profit: 973.61 million CNY - Net profit year-on-year growth: 45.51% - Revenue: 5347.74 million CNY - Revenue year-on-year growth: 20.89% [1] - **Darui Electric (300976)** - Earnings per share: 1.7500 CNY - Net profit: 231.02 million CNY - Net profit year-on-year growth: 26.84% - Revenue: 2278.36 million CNY - Revenue year-on-year growth: 28.59% [1] - **Huiquan Brewery (600573)** - Earnings per share: 0.3940 CNY - Net profit: 98.56 million CNY - Net profit year-on-year growth: 23.70% - Revenue: 575.73 million CNY - Revenue year-on-year growth: -2.59% [1] - **Xiangsheng Medical (688358)** - Earnings per share: 0.8400 CNY - Net profit: 93.92 million CNY - Net profit year-on-year growth: -4.56% - Revenue: 343.17 million CNY - Revenue year-on-year growth: -5.27% [1] - **Xiangfenghua (300890)** - Earnings per share: 0.1676 CNY - Net profit: 19.95 million CNY - Net profit year-on-year growth: -64.64% - Revenue: 1130.90 million CNY - Revenue year-on-year growth: 8.16% [1] - **Tongyou Technology (300302)** - Earnings per share: 0.0194 CNY - Net profit: 0.93 million CNY - Net profit year-on-year growth: -70.37% - Revenue: 32.72 million CNY - Revenue year-on-year growth: 7.73% [1] - **Shenglong Shares (603178)** - Earnings per share: -0.3100 CNY - Net profit: -72.95 million CNY - Net profit year-on-year growth: -1163.12% - Revenue: 1253.80 million CNY - Revenue year-on-year growth: 10.35% [1]
10月20日早间重要公告一览
Xi Niu Cai Jing· 2025-10-20 03:58
Group 1 - Xuedilong plans to invest no more than 400 million yuan to build an innovation industrial base in Changping District, Beijing, focusing on chromatography and mass spectrometry production lines [1] - The project aims to enhance research and production capabilities in carbon monitoring and measurement systems [1] Group 2 - Zejing Pharmaceutical's tri-specific antibody drug ZGGS34 has received clinical trial approval from the National Medical Products Administration for treating MUC17 positive advanced solid tumors [2] - The drug shows strong anti-tumor activity and good safety in preclinical studies [2] Group 3 - Aosaikang's new cMET inhibitor ASK202 will present clinical research data at the 2025 ESMO annual meeting, showing an objective response rate of 68.8% and a disease control rate of 93.8% in advanced non-small cell lung cancer patients [2][3] Group 4 - China Life expects a net profit of 156.785 billion to 177.689 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 50% to 70% [4] Group 5 - Silan Microelectronics plans to jointly invest 5.1 billion yuan to build a 12-inch high-end analog chip production line, with a total project investment of 20 billion yuan [5][6] Group 6 - New City intends to use 156.65 million yuan of remaining fundraising to invest in a "Building Green Energy and Zero Carbon Park" project, with a total investment of 257 million yuan [8] Group 7 - Yidao Information plans to acquire control of Guangzhou Langguo Electronic Technology and Shenzhen Chengwei Information through a combination of share issuance and cash payment [9] Group 8 - Xiling Information's controlling shareholder has received a notice of lifting restrictions, allowing normal business operations to resume [10] Group 9 - Dongpeng Holdings' first batch of rock slab products has passed the highest level 5A quality inspection, becoming one of the first companies to meet the new national standard [11] Group 10 - Aonlikang's levofloxacin tablets have received approval from the National Medical Products Administration, classified as a chemical drug of category 4 [15] Group 11 - Haizheng Pharmaceutical's Taizhou factory has had its GMP non-compliance declaration revoked by the EU, confirming compliance with EU GMP requirements [17][18] Group 12 - Hongfuhan's shareholder plans to reduce its stake by up to 1.5% through various trading methods due to asset integration and funding needs [19] Group 13 - Purang Co. plans to establish a wholly-owned subsidiary in Hong Kong to enhance its international competitiveness and service levels [20] Group 14 - Tianhe Magnetic Materials' subsidiary has signed an investment agreement for a project worth 850 million yuan focused on high-performance rare earth permanent magnets [22] Group 15 - Xiangfenghua reported a 64.64% year-on-year decline in net profit for the first three quarters, despite an 8.16% increase in revenue [23] Group 16 - Darui Electronics reported a 26.84% year-on-year increase in net profit for the first three quarters, with total revenue growing by 28.59% [24] Group 17 - Xiangsheng Medical reported a 4.56% year-on-year decline in net profit for the first three quarters, despite a 41.95% increase in net profit for the third quarter [25]
晚间公告丨10月19日这些公告有看头
第一财经· 2025-10-19 13:46
Core Viewpoint - Multiple companies in the Shanghai and Shenzhen stock markets have announced significant developments, including investments in semiconductor manufacturing, clinical research advancements, and changes in corporate governance, which may present investment opportunities and insights for stakeholders [3]. Investment Announcements - Silan Microelectronics plans to invest 20 billion yuan to establish a 12-inch high-end analog integrated circuit chip manufacturing line, aiming for a production capacity of 54 million chips annually after completion [4]. - Xidilong intends to invest no more than 400 million yuan to purchase land use rights and build an innovation industrial base, adding chromatography and mass spectrometry production lines [8]. - Tianhe Magnetic Materials' subsidiary plans to invest 850 million yuan in high-performance rare earth permanent magnets and component manufacturing [9]. - New City plans to allocate 157 million yuan of remaining fundraising to a green energy and zero-carbon park planning project [10]. - Yanguang Nuohuo proposes to invest 15 million yuan to increase the registered capital of Yuanma Zhiyao, focusing on innovative CAR-T cell therapies [15]. Corporate Governance Changes - Xiling Information's controlling shareholder and general manager has had their detention lifted, allowing them to resume normal duties [5][6]. Regulatory Developments - Haizheng Pharmaceutical's Taizhou factory has had its GMP non-compliance status revoked by the EU, positively impacting its product sales in the EU market [7]. - Zhonghe Titanium White will change its stock name to "Titanium Energy Chemical" starting October 20, 2025, while retaining its stock code [14]. Performance Reports - China Life expects a net profit increase of approximately 50% to 70% for the first three quarters of 2025, estimating profits between 156.785 billion yuan and 177.689 billion yuan [20]. - Yangjie Technology reported a 52.4% increase in net profit for Q3 2025, driven by growth in the semiconductor sector [21]. - Xiangsheng Medical's Q3 net profit grew by 41.95%, despite a decline in revenue [22]. - Zhuhai Guanyu anticipates a net profit increase of 36.88% to 55.54% for the first three quarters of 2025 [23]. - Huiquan Beer reported a 23.7% increase in net profit for Q3 2025 [24]. - Darui Electronics' net profit grew by 26.84% in the first three quarters of 2025 [25]. - Xingwang Yuda turned a profit in Q3 2025, reporting a net profit of 38.3749 million yuan [27]. - Tongyou Technology reported a net profit of 27.6683 million yuan in Q3 2025, marking a turnaround from losses [28]. Shareholding Changes - Hongfuhan's shareholder, Hengmei International, plans to reduce its stake by up to 1.5% [30]. - Intelligent Control's controlling shareholder's associate plans to reduce its stake by up to 1% [31].
达瑞电子:前三季度净利润同比增长26.84%
Mei Ri Jing Ji Xin Wen· 2025-10-19 09:10
Core Insights - Darui Electronics (300976.SZ) reported a revenue of 2.278 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 28.59% [2] - The net profit attributable to shareholders of the listed company reached 231 million yuan, marking a year-on-year increase of 26.84% [2] Financial Performance - Revenue for the first three quarters: 2.278 billion yuan, up 28.59% year-on-year [2] - Net profit attributable to shareholders: 231 million yuan, up 26.84% year-on-year [2]